Skin exams are getting automated.
What’s happening: SquareMind announced $18M to scale its AI-powered, full-body robotic skin imaging platform across the US and EU.
Auto-exam. Optimizing the typical manual spot-check process, its freestanding Swan robot captures dermoscopic images across the entire skin surface in minutes, while its AI-enabled system tracks new and changing moles over time, integrating into clinical workflows.
Skin check. With skin cancer impacting 20% of Americans and diagnoses on the rise, screenings are dermatology’s highest-volume procedure. As demand outpaces supply long wait times are lengthening, leading many to delay care.
Rewiring the $5B derm diagnostics market, AI-assisted care stands to improve outcomes, address appointment shortages, establish bulletproof screening guidelines, and reduce clinician burden.
Scanning. As clinical workflows become increasingly automated, their longitudinal pattern recognition capabilities make dermatology a prime use case.
Democratizing 3D scans, Neko Health’s scan can assess 2K+ marks in seven seconds, while DermaSensor scored $16M and an FDA clearance for its handheld melanoma screening device.
At-home checkups, YOU(th) raised $4.5M for its smartphone health diagnostics, while NOVOS’ FaceAge and L’Oréal’s Skin Genius quantify skin aging biomarkers.
Punchline: Determined to clear waiting lists, SquareMind is turning skin exams into a scalable, data-driven procedure — pushing dermatology toward a new standard of care.
